Hormonal changes driven by menopause can cause symptoms that affect sleep, energy, mood, sexual health, and sometimes the overall quality of life. Hot flashes, night sweats, vaginal dryness, sleep problems, and difficulty concentrating are among the most common concerns.
For women with moderate to severe symptoms, menopausal hormone therapy (often called hormone replacement therapy or HRT) is a good treatment to consider.
How Hormone Therapy Works
During perimenopause and menopause, the ovaries gradually produce less estrogen and progesterone. Hormone therapy supplements these declining hormone levels to help manage symptoms.
Systemic estrogen therapy, available in forms such as pills, patches, gels, and sprays, would be the most effective treatment for hot flashes and night sweats. Women who still have a uterus generally also need progesterone or a progestogen to protect the uterine lining from the increased risk of endometrial cancer associated with estrogen alone.
For women whose primary symptoms are vaginal dryness, discomfort during sex, or certain urinary symptoms, low-dose vaginal estrogen may be recommended instead or in addition to the systemic therapy.
Benefits Beyond Hot Flashes
Hormone therapy can improve several symptoms associated with menopause, including sleep disruption. This can alleviate fatigue, difficulty concentrating, or mood changes.
Estrogen helps protect bone density and hormone therapy has been shown to reduce bone loss and fracture risk.
Hormonal changes may also contribute to changes in skin thickness, dryness, and collagen production. However, hormone therapy is not currently recommended specifically as an anti-aging, weight-loss, hair-restoration, or cosmetic treatment.
Understanding the Risks
Hormone therapy will not be an ideal fit for every woman. Individual use will depend on age, medical history, family history, the type of hormones prescribed, dosage, and how the medication is delivered.
For most healthy women experiencing bothersome menopause symptoms, the benefit-risk profile is generally most favorable when hormone therapy is started before age 60 or within approximately 10 years of menopause.
Potential risks can include blood clots, stroke, gallbladder disease, and, with some forms of combined estrogen-progestogen therapy, an increased risk of breast cancer. Transdermal estrogen, such as patches or gels, may carry a lower risk of blood clots than oral estrogen for some patients.
In February 2026, the FDA approved labeling changes for six menopausal hormone therapy products, removing certain cardiovascular disease, breast cancer, and dementia statements from their boxed warnings. The change reflects a more individualized understanding of hormone therapy rather than the broad risk assumptions commonly associated with HRT in previous decades.
A Personalized Approach to Menopause Care
There is no single hormone therapy plan that is appropriate for every woman. Treatment should be based on symptoms, health history, personal risk factors, and individual goals.
For women struggling with menopause symptoms, a medical consultation can help determine whether hormone therapy or a nonhormonal alternative. Contact our team at Lasting Skin Solutions for a consultation.
